Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial (Q44234273)
Jump to navigation
Jump to search
scientific article published in December 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial |
scientific article published in December 2002 |
Statements
1 reference
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial (English)
1 reference
Susan L Greenspan
1 reference
Ronald D Emkey
1 reference
Henry G Bone
1 reference
Stuart R Weiss
1 reference
Norman H Bell
1 reference
Robert W Downs
1 reference
Clark McKeever
1 reference
Sam S Miller
1 reference
Michael Davidson
1 reference
Michael A Bolognese
1 reference
Anthony L Mulloy
1 reference
Norman Heyden
1 reference
Mei Wu
1 reference
Amarjot Kaur
1 reference
Antonio Lombardi
1 reference
1 December 2002
1 reference
1 reference
Identifiers
1 reference